Committee members disclosed the following financial or other conflicts of interest covering the period 12 months before 7 September 2014

MemberEmploymentResearch grantOther research support
Richard W. Grant, MD, MPH (Chair) Division of Research, Kaiser Permanente, Oakland, CA NIDDK, NHLBI None 
Thomas W. Donner, MD Johns Hopkins University School of Medicine, Baltimore, MD Novo Nordisk*# None 
Judith E. Fradkin, MD National Institutes of Health, Bethesda, MD None None 
Charlotte Hayes, MMSc, MS, RD, CDE, ACSM CES Private practice: (NF)2 Nutrition and Fitness Consulting, Atlanta, GA None None 
William H. Herman, MD, MPH University of Michigan, Ann Arbor, MI None None 
William C. Hsu, MD Joslin Diabetes Center, Boston, MA None None 
Eileen Kim, MD Kaiser Permanente Northern California Region, Oakland, CA None None 
Lori Laffel, MD, MPH Joslin Diabetes Center and Harvard Medical School, Boston, MA Dexcom, Boehringer Ingelheim None 
Rodica Pop-Busui, MD, PhD University of Michigan, Ann Arbor, MI NHLBI, NIDDK,
ADA, Bristol-Myers Squibb 
None 
Neda Rasouli, MD University of Colorado, Denver, CO Novo Nordisk,# Bristol-Myers Squibb,# Merck Sharp & Dohme,# NIDDK,# Pfizer# None 
Desmond Schatz, MD University of Florida, Gainesville, FL None NIDDK, NIAID, Jaeb Center for Health Research, JDRF, Helmsley Charitable Trust 
Joseph A. Stankaitis, MD, MPH Monroe Plan for Medical Care, Rochester, NY Milbank Memorial Fund None 
Tracey H. Taveira, PharmD, CDOE, CVDOE University of Rhode Island College of Pharmacy, Kingston, RI; Providence VA Medical Center, Warren Alpert Medical School of Brown University, Providence, RI AHA None 
Deborah J. Wexler, MD Massachusetts General Hospital, Boston, MA NIDDK None 
Jane L. Chiang, MD (Staff) ADA, Alexandria, VA None None 
Erika Gebel Berg, PhD (Staff) ADA, Alexandria, VA None None 
MemberEmploymentResearch grantOther research support
Richard W. Grant, MD, MPH (Chair) Division of Research, Kaiser Permanente, Oakland, CA NIDDK, NHLBI None 
Thomas W. Donner, MD Johns Hopkins University School of Medicine, Baltimore, MD Novo Nordisk*# None 
Judith E. Fradkin, MD National Institutes of Health, Bethesda, MD None None 
Charlotte Hayes, MMSc, MS, RD, CDE, ACSM CES Private practice: (NF)2 Nutrition and Fitness Consulting, Atlanta, GA None None 
William H. Herman, MD, MPH University of Michigan, Ann Arbor, MI None None 
William C. Hsu, MD Joslin Diabetes Center, Boston, MA None None 
Eileen Kim, MD Kaiser Permanente Northern California Region, Oakland, CA None None 
Lori Laffel, MD, MPH Joslin Diabetes Center and Harvard Medical School, Boston, MA Dexcom, Boehringer Ingelheim None 
Rodica Pop-Busui, MD, PhD University of Michigan, Ann Arbor, MI NHLBI, NIDDK,
ADA, Bristol-Myers Squibb 
None 
Neda Rasouli, MD University of Colorado, Denver, CO Novo Nordisk,# Bristol-Myers Squibb,# Merck Sharp & Dohme,# NIDDK,# Pfizer# None 
Desmond Schatz, MD University of Florida, Gainesville, FL None NIDDK, NIAID, Jaeb Center for Health Research, JDRF, Helmsley Charitable Trust 
Joseph A. Stankaitis, MD, MPH Monroe Plan for Medical Care, Rochester, NY Milbank Memorial Fund None 
Tracey H. Taveira, PharmD, CDOE, CVDOE University of Rhode Island College of Pharmacy, Kingston, RI; Providence VA Medical Center, Warren Alpert Medical School of Brown University, Providence, RI AHA None 
Deborah J. Wexler, MD Massachusetts General Hospital, Boston, MA NIDDK None 
Jane L. Chiang, MD (Staff) ADA, Alexandria, VA None None 
Erika Gebel Berg, PhD (Staff) ADA, Alexandria, VA None None 

ADA, American Diabetes Association; AHA, American Heart Association; MEDCAC, Medicare Evidence Development & Coverage Advisory Committee; NHLBI, National Heart, Lung, and Blood Institute; NIAID, National Institute of Allergy and Infectious Diseases; NIDDK, National Institute of Diabetes and Digestive and Kidney Diseases.

*≥$10,000 per year from company to individual.

#Grant or contract is to university or other employer.

MemberSpeakers’ bureau/honorariaOwnership interestConsultant/advisory boardOther
R.W.G. None None None None 
T.W.D. None None None None 
J.E.F. None None None None 
C.H. Scherer Clinical Communications None Emory University, Emory Diabetes Course at Grady, Team Novo Nordisk Receives royalties from the ADA, Academy of Nutrition and Dietetics (Chair, Legislative and Public Policy Committee) 
W.H.H. None None AstraZeneca, Novo Nordisk (self and spouse), Merck Sharp & Dohme,* GI Dynamics, Boehringer Ingelheim National Committee for Quality Assurance (Chair, Diabetes Panel), Centers for Medicare & Medicaid Services (member, MEDCAC), Diabetic Medicine (Editor for the Americas) 
W.C.H. None None Novo Nordisk None 
E.K. None None None None 
L.L. None None Johnson & Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb, Menarini, Novo Nordisk, AstraZeneca, LifeScan/Animas, Boehringer Ingelheim, Dexcom None 
R.P.-B. None None Acorda Therapeutics,
AstraZeneca,
T1D Exchange 
None 
N.R. None None None None 
D.S. None None Daiichi Sankyo, Andromeda Biotech ADA Board of Directors, ADA officer 
J.A.S. None None TPG National Payor Roundtable, Amgen, Celgene, Gilead, Salix Pharmaceuticals, Janssen Pharmaceuticals, Bayer, Medtronic National Committee for Quality Assurance (physician surveyor and member of Reconsideration Committee), New York State Department of Health Medicaid Redesign Team’s Evidence-Based Benefit Review Workgroup, Board member (Chair-Elect) for St. Ann’s Community, Rochester, NY, a non-profit senior living/long-term care organization 
T.H.T. None None None None 
D.J.W. None None None Diabetes Care (Editorial Board) 
J.L.C. None None None None 
E.G.B. None None None None 
MemberSpeakers’ bureau/honorariaOwnership interestConsultant/advisory boardOther
R.W.G. None None None None 
T.W.D. None None None None 
J.E.F. None None None None 
C.H. Scherer Clinical Communications None Emory University, Emory Diabetes Course at Grady, Team Novo Nordisk Receives royalties from the ADA, Academy of Nutrition and Dietetics (Chair, Legislative and Public Policy Committee) 
W.H.H. None None AstraZeneca, Novo Nordisk (self and spouse), Merck Sharp & Dohme,* GI Dynamics, Boehringer Ingelheim National Committee for Quality Assurance (Chair, Diabetes Panel), Centers for Medicare & Medicaid Services (member, MEDCAC), Diabetic Medicine (Editor for the Americas) 
W.C.H. None None Novo Nordisk None 
E.K. None None None None 
L.L. None None Johnson & Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb, Menarini, Novo Nordisk, AstraZeneca, LifeScan/Animas, Boehringer Ingelheim, Dexcom None 
R.P.-B. None None Acorda Therapeutics,
AstraZeneca,
T1D Exchange 
None 
N.R. None None None None 
D.S. None None Daiichi Sankyo, Andromeda Biotech ADA Board of Directors, ADA officer 
J.A.S. None None TPG National Payor Roundtable, Amgen, Celgene, Gilead, Salix Pharmaceuticals, Janssen Pharmaceuticals, Bayer, Medtronic National Committee for Quality Assurance (physician surveyor and member of Reconsideration Committee), New York State Department of Health Medicaid Redesign Team’s Evidence-Based Benefit Review Workgroup, Board member (Chair-Elect) for St. Ann’s Community, Rochester, NY, a non-profit senior living/long-term care organization 
T.H.T. None None None None 
D.J.W. None None None Diabetes Care (Editorial Board) 
J.L.C. None None None None 
E.G.B. None None None None